Study title:
A double-blind single dose evaluation of the efficacy and safety of ibuprofen 400 mg, ibuprofen 200 mg, APAP 1000 mg, and placebo in the treatment of pain following removal of the impacted third molarsA double-blind single dose evaluation of the efficacy and safety of ibuprofen 400 mg, ibuprofen 200 mg, APAP 1000 mg, and placebo in the treatment of pain following removal of the impacted third molars
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Anesthesia and Analgesia [E03]
|
Brands: Please see report, Please see report, Please see report, Please see report |
MAH holders: Please see report, Please see report |
Assessment: |
Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|